Clinical Evidence and Safety Profile of Emicizumab for the Management of Children with Hemophilia A

Sandra Le Quellec1,2 1Unité d’hémostase Clinique – Hôpital Cardiologique Louis Pradel – Hospices Civils de Lyon, Lyon, France; 2Service d’hématologie biologique, Groupement Hospitalier Est – Hospices Civils de Lyon, Lyon, FranceCorrespondence:...

Ausführliche Beschreibung

Bibliografische Detailangaben

1. Verfasser:	Le Quellec S
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Dove Medical Press 2020-02-01
Schriftenreihe:	Drug Design, Development and Therapy
Schlagworte:	emicizumab hemophilia a inhibitors factor viii prophylaxis subcutaneous
Online-Zugang:	https://www.dovepress.com/clinical-evidence-and-safety-profile-of-emicizumab-for-the-management--peer-reviewed-article-DDDT
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!